These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21809673)

  • 1. [Renal carcinoma in childhood].
    Ismail-zade RS
    Vopr Onkol; 2011; 57(2):241-4. PubMed ID: 21809673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma.
    Ismail-Zade RS; Zhavrid EA; Potapnev MP
    Pediatr Blood Cancer; 2005 Jun; 44(7):679-81. PubMed ID: 15700247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant interleukin-2, interferon-alpha, and 5-fluorouracil immunochemotherapy after radical nephrectomy for locally advanced renal cell carcinoma.
    Hong SK; Kwak C; Lee SE
    Urology; 2005 Sep; 66(3):518-22. PubMed ID: 16140069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in pT3N0M0 renal cell carcinoma.
    Jeon SH; Chang SG; Kim JI
    Anticancer Res; 1999; 19(6C):5593-7. PubMed ID: 10697624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
    Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
    Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clear cell carcinoma of the kidney in an 8-year-old boy].
    Bukowski M
    Pediatr Pol; 1995 Nov; 70(11):973-5. PubMed ID: 8677165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-α-based immunotherapy in metastatic renal cell carcinoma patients with the primary tumor in situ.
    Shinohara N; Abe T; Sazawa A; Maruyama S; Shindo J; Sato S; Suzuki S; Nonomura K
    Jpn J Clin Oncol; 2012 Feb; 42(2):113-9. PubMed ID: 22131341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
    Shuch B; La Rochelle JC; Wu J; Klatte T; Riggs SB; Kabbinavar F; Belldegrun AS; Pantuck AJ
    Cancer; 2008 Sep; 113(6):1324-31. PubMed ID: 18661529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT2-3N0M0 renal cell carcinoma?
    Migliari R; Muscas G; Solinas A; Melis M; Ionta MT; Massidda B; Usai E
    J Chemother; 1995 Jun; 7(3):240-5. PubMed ID: 7562021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Organ-sparing surgery for nephroblastoma in children].
    Ismail-zade RS; Kochubinskiĭ DV; Shimanskiĭ AT; Nazaruk SI; Rutskaia EA; Begin IV; Fedorova AS; Savva NN; Vydanov OI
    Vopr Onkol; 2012; 58(4):502-6. PubMed ID: 23607205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.
    Furtwängler R; Gooskens SL; van Tinteren H; de Kraker J; Schleiermacher G; Bergeron C; de Camargo B; Acha T; Godzinski J; Sandstedt B; Leuschner I; Vujanic GM; Pieters R; Graf N; van den Heuvel-Eibrink MM
    Eur J Cancer; 2013 Nov; 49(16):3497-506. PubMed ID: 23880476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced pediatric renal cell carcinoma.
    Ambalavanan M; Geller JI
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27766. PubMed ID: 31012542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of the preoperative treatment of advanced Wilms tumor in children with chemotherapy versus transcatheter arterial chemoembolization alone or combined with short-term systemic chemotherapy.
    Li MJ; Zhou YB; Huang Y; Tang DX; Xu S; Wu DH; Zhang YY; Tang HF
    J Vasc Interv Radiol; 2011 Mar; 22(3):279-86. PubMed ID: 21353980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of renal cell carcinoma in children: a report from the Polish pediatric rare tumor study group.
    Stachowicz-Stencel T; Bien E; Balcerska A; Godzinski J; Synakiewicz A; Perek-Polnik M; Kurylak A; Pietras W; Kuzmicz M; Mizia-Malarz A; Rybczynska A; Nurzynska-Flak J
    Klin Padiatr; 2011 May; 223(3):138-41. PubMed ID: 21509711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
    Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
    Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clear cell renal carcinoma in children. Study of two cases and review of the literature].
    Walter P; Vetter JM
    Ann Pediatr (Paris); 1976 Sep; 23(8-9):541-50. PubMed ID: 16104190
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.
    Messing EM; Manola J; Wilding G; Propert K; Fleischmann J; Crawford ED; Pontes JE; Hahn R; Trump D;
    J Clin Oncol; 2003 Apr; 21(7):1214-22. PubMed ID: 12663707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trial.
    Rini BI; Bellmunt J; Clancy J; Wang K; Niethammer AG; Hariharan S; Escudier B
    J Clin Oncol; 2014 Mar; 32(8):752-9. PubMed ID: 24297945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma: results of a phase III randomised European Organisation for Research and Treatment of Cancer (Genito-Urinary Cancers Group)/National Cancer Research Institute trial.
    Aitchison M; Bray CA; Van Poppel H; Sylvester R; Graham J; Innes C; McMahon L; Vasey PA
    Eur J Cancer; 2014 Jan; 50(1):70-7. PubMed ID: 24074763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter phase II trial of combination therapy with meloxicam, a cox-2 inhibitor, and natural interferon-alpha for metastatic renal cell carcinoma.
    Shinohara N; Kumagai A; Kanagawa K; Maruyama S; Abe T; Sazawa A; Nonomura K
    Jpn J Clin Oncol; 2009 Nov; 39(11):720-6. PubMed ID: 19684042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.